Back
Repligen Stock Predictions
Buy
62
RGEN
Repligen
Last Price:
171.86
Seasonality Move:
5.99%
7 Day Trial
ALL ACCESS PASS
$
7
Repligen Stock Forecast
- Over the next 52 weeks, Repligen has on average historically risen by 19% based on the past 38 years of stock performance.
- Repligen has risen higher in 22 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%
-
Is Repligen Stock Undervalued?
The current Repligen [RGEN] share price is $171.94. The Score for RGEN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal. - RGEN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Repligen Stock Go Up Next Year?
- Over the next 52 weeks, Repligen has on average historically risen by 19% based on the past 38 years of stock performance.
Repligen Stock Rating
Buy
62
Repligen (RGEN)
is a Buy
Is Repligen overpriced?
- Repligen has risen higher in 22 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%
Repligen Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
repligen.com
52-Week Data
52-Week High:
211.13
52-Week Low:
110.45
Prediction Charts
Market Cap:
9.61B
Price in USD:
171.94
Volume:
456.1K
Beta:
0.99
Technical Analysis
SMA50:
175.86
SMA100:
182.58
SMA200:
170.73
52-Wk Change:
12.36%
Stock Predictions
-
Is Repligen stock public?
Yes, Repligen is a publicly traded company. -
What is the Repligen stock quote today?
The Repligen stock price is 171.94 USD today. -
How to buy Repligen stock online?
You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-30 | 164.54 | 164.46 | 168.28 | 164.01 |
May-1 | 159.00 | 158.20 | 164.15 | 151.82 |
May-2 | 160.61 | 166.31 | 166.71 | 155.48 |
May-3 | 170.10 | 167.05 | 172.00 | 166.43 |
May-6 | 168.68 | 168.04 | 168.68 | 165.91 |
May-7 | 168.34 | 167.72 | 169.22 | 165.99 |
May-8 | 165.94 | 165.50 | 168.30 | 165.07 |
May-9 | 165.35 | 164.82 | 166.38 | 161.77 |
May-10 | 164.70 | 166.81 | 167.43 | 163.83 |
May-13 | 166.80 | 163.34 | 169.62 | 163.07 |
May-14 | 165.73 | 172.48 | 173.35 | 164.51 |
May-15 | 174.42 | 176.03 | 176.94 | 172.53 |
May-16 | 174.93 | 171.03 | 175.99 | 170.82 |
May-17 | 170.81 | 171.94 | 172.11 | 168.51 |
Repligen Earnings
Repligen Earnings Report: Per Share Repligen Earnings Q1 Q2 Q3 and Q4 last year and next year.
Repligen Forecast Revenue Growth
Repligen Stock Analysis: Historical quarterly revenues per share for Repligen and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.22 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.28 per share, and an increase next year of $0.56 per share.
* Repligen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.